−0.90 TWD
−70.83 M TWD
46.07 M TWD
90.78 M
About INNOPHARMAX INC
Sector
CEO
Wei Hua Hao
Headquarters
Taipei
Website
Founded
2005
ISIN
TW0004172002
FIGI
BBG003CC2VR3
InnoPharmax, Inc. engages in the development and commercialization of pharmaceutical products for the treatment of oncology and specialty. Its product categories include anti-infection agents, contrast agents, oncology agents, immunological agents, and drugs for rare diseases. The company was founded on October 27, 2005 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4172 is 17.00 TWD — it has decreased by −0.29% in the past 24 hours. Watch INNOPHARMAX INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange INNOPHARMAX INC stocks are traded under the ticker 4172.
4172 stock has fallen by −4.23% compared to the previous week, the month change is a −11.92% fall, over the last year INNOPHARMAX INC has showed a −2.19% decrease.
4172 reached its all-time high on May 9, 2014 with the price of 85.15 TWD, and its all-time low was 6.45 TWD and was reached on Nov 27, 2018. View more price dynamics on 4172 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4172 stock is 5.15% volatile and has beta coefficient of 0.39. Track INNOPHARMAX INC stock price on the chart and check out the list of the most volatile stocks — is INNOPHARMAX INC there?
Today INNOPHARMAX INC has the market capitalization of 1.83 B, it has decreased by −3.24% over the last week.
Yes, you can track INNOPHARMAX INC financials in yearly and quarterly reports right on TradingView.
4172 net income for the last half-year is −42.54 M TWD, while the previous report showed −40.98 M TWD of net income which accounts for −3.82% change. Track more INNOPHARMAX INC financial stats to get the full picture.
No, 4172 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOPHARMAX INC EBITDA is −73.62 M TWD, and current EBITDA margin is −125.01%. See more stats in INNOPHARMAX INC financial statements.
Like other stocks, 4172 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOPHARMAX INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOPHARMAX INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOPHARMAX INC stock shows the sell signal. See more of INNOPHARMAX INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.